Fulcrum Therapeutics (FULC) News Today $7.83 -0.18 (-2.25%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$7.84 +0.00 (+0.06%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FULC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing ...July 12 at 6:28 PM | morningstar.comMFulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 11 at 4:30 PM | globenewswire.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives $6.29 Consensus PT from AnalystsJuly 6, 2025 | americanbankingnews.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Recommendation of "Moderate Buy" by AnalystsJuly 3, 2025 | marketbeat.comFulcrum Therapeutics (NASDAQ:FULC) investors are sitting on a loss of 60% if they invested five years agoJune 28, 2025 | finance.yahoo.comFulcrum Therapeutics Inc. Annual Cash Flow Statement - MarketWatchJune 25, 2025 | marketwatch.comCantor Fitzgerald Reaffirms Their Buy Rating on Fulcrum Therapeutics (FULC)June 22, 2025 | theglobeandmail.comResearch Analysts Set Expectations for FULC FY2026 EarningsJune 11, 2025 | marketbeat.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Acquired by Millennium Management LLCJune 11, 2025 | marketbeat.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Sold by Two Sigma Investments LPJune 8, 2025 | marketbeat.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJune 8, 2025 | marketbeat.comFulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 6, 2025 | globenewswire.comMackenzie Financial Corp Has $555,000 Stock Holdings in Fulcrum Therapeutics, Inc. (NASDAQ:FULC)June 3, 2025 | marketbeat.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Short Interest UpdateJune 2, 2025 | marketbeat.comTwo Sigma Advisers LP Sells 38,600 Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC)May 31, 2025 | marketbeat.comFulcrum Therapeutics, Inc. (FULC): A Bull Case TheoryMay 30, 2025 | msn.comFulcrum Therapeutics to Present at Upcoming Medical MeetingsMay 29, 2025 | globenewswire.comFulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare ConferenceMay 29, 2025 | globenewswire.comLeerink raises Fulcrum Therapeutics stock to OutperformMay 26, 2025 | uk.investing.comFulcrum Therapeutics (NASDAQ:FULC) Upgraded by Leerink Partnrs to "Strong-Buy" RatingMay 26, 2025 | marketbeat.comWoodline Partners LP Increases Holdings in Fulcrum Therapeutics, Inc. (NASDAQ:FULC)May 26, 2025 | marketbeat.comNorthern Trust Corp Buys 142,578 Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC)May 26, 2025 | marketbeat.comFulcrum Therapeutics (NASDAQ:FULC) Upgraded to Outperform at Leerink PartnersMay 25, 2025 | marketbeat.comLeerink Partners Upgrades Fulcrum Therapeutics (FULC)May 23, 2025 | msn.comFulcrum gains as Leerink upgrades ahead of data for lead assetMay 23, 2025 | msn.comSherbrooke Park Advisers LLC Has $212,000 Stock Holdings in Fulcrum Therapeutics, Inc. (NASDAQ:FULC)May 23, 2025 | marketbeat.comFulcrum Therapeutics at RBC Capital: Strategic Steps in Sickle Cell TreatmentMay 23, 2025 | uk.investing.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Sold by D. E. Shaw & Co. Inc.May 22, 2025 | marketbeat.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Purchased by Suvretta Capital Management LLCMay 19, 2025 | marketbeat.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Acquired by Graham Capital Management L.P.May 17, 2025 | marketbeat.comCantor Fitzgerald Upgrades Fulcrum Therapeutics (FULC)May 16, 2025 | msn.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Rating of "Reduce" by AnalystsMay 16, 2025 | marketbeat.comCAMP4 Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial ResultsMay 15, 2025 | nasdaq.comCisco upgraded, CoreWeave downgraded: Wall Street's top analyst callsMay 15, 2025 | finance.yahoo.comBridgeway Capital Management LLC Purchases New Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC)May 14, 2025 | marketbeat.comFulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 9, 2025 | globenewswire.comFulcrum Therapeutics (FULC) Projected to Post Earnings on MondayMay 7, 2025 | marketbeat.comFulcrum Therapeutics (NASDAQ:FULC) Announces Earnings Results, Beats Estimates By $0.01 EPSMay 5, 2025 | marketbeat.comBoothbay Fund Management LLC Reduces Stake in Fulcrum Therapeutics, Inc. (NASDAQ:FULC)May 5, 2025 | marketbeat.comSusquehanna Fundamental Investments LLC Purchases Shares of 213,213 Fulcrum Therapeutics, Inc. (NASDAQ:FULC)May 4, 2025 | marketbeat.comEarnings call transcript: Fulcrum Therapeutics Q1 2025 reveals improved net lossMay 3, 2025 | uk.investing.comFulcrum Therapeutics, Inc. (FULC) Q1 2025 Earnings Call TranscriptMay 2, 2025 | seekingalpha.comFulcrum therapeutics targets key data from PIONEER trial in Q3 2025May 2, 2025 | msn.comQ1 2025 Fulcrum Therapeutics Inc Earnings CallMay 2, 2025 | finance.yahoo.comFulcrum Therapeutics Inc (FULC) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions and ...May 2, 2025 | finance.yahoo.comFulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2025May 1, 2025 | globenewswire.com2FULC : Uncovering Potential: Fulcrum Therapeutics's Earnings PreviewApril 30, 2025 | benzinga.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Acquired by Adage Capital Partners GP L.L.C.April 30, 2025 | marketbeat.comFulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ETApril 24, 2025 | globenewswire.comFulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Average Recommendation of "Hold" from BrokeragesApril 21, 2025 | marketbeat.com Get Fulcrum Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FULC and its competitors with MarketBeat's FREE daily newsletter. Email Address FULC Media Mentions By Week FULC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FULC News Sentiment▼0.630.99▲Average Medical News Sentiment FULC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FULC Articles This Week▼33▲FULC Articles Average Week Get Fulcrum Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FULC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BHVN News Today EVO News Today ETNB News Today JANX News Today ANIP News Today EWTX News Today MESO News Today TVTX News Today CVAC News Today CALT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FULC) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulcrum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulcrum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.